Foreground Capital | Activity | F4Foreground Capital Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Investment
Participated in Allara's $30M financing for insurance-covered women's healthcare.
Allara
Participated in the HITLAB March 2026 Symposium.
HITLAB March 2026 Symposium
Essay
Featured in an SVB piece arguing women's health is the blueprint for the future of healthcare.
Why women's health is the blueprint for the future of healthcare
Podcast
Partner Alice Zheng discussed a career in VC and women's health investing with Dr. Nisha Mehta.
Alice Zheng on a career in VC and women's health investing
News
CBS San Francisco covered a conference highlighting the profitability of women's health care, listed in Foreground's news.
CBS San Francisco on women's health care profitability conference
4 investments· FEB 2025 – JUL 2025Show all
Investment
Invested in Gesynta Pharma's Series B.
Gesynta Pharma
Investment
Invested in Eli Health's Series A.
Eli Health
Investment
Invested in Cofertility's Series A.
Cofertility
Investment
Invested in Millie's Series A.
Millie
Press
Alice Zheng discussed women's health investment growth and the private sector's role with MobiHealthNews.
Q&A on women's health funding in 2025
News
The RH Capital team spun out of Rhia Ventures as Foreground Capital, effective October 1, 2024, and continues to manage RH Capital Funds I and II.
Foreground Capital launches as independent firm